Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels

Obstetrics and gynecology, 59(3), 275-279

PMID 7078874 Source

Abstract

Sixty-nine infertile women with a midluteal serum progesterone level of 4 to 14 ng/ml were treated with a graduated dosage schedule of clomiphene citrate until the progesterone level on day 21 was greater than 20 ng/ml. Thirty-one pregnancies occurred, 58% during the first adequate treatment cycle and 19% during the second cycle. The abortion rate was 23%. After 6 adequate treatment cycles, laparoscopic evaluation was performed on 28 of 39 patients who did not conceive. Pathology was noted in 57%. Seven of 17 patients with intraperitoneal causes of infertility conceived after alternative therapy. The corrected pregnancy rate was 60%. Results of this study suggest that low luteal phase progesterone levels may compromise fertility and that clomiphene citrate enhances pregnancy rates.

Topics

luteal phase deficiency clomiphene treatment, low progesterone infertility clomiphene citrate, midluteal progesterone clomiphene therapy, clomiphene ovulation induction luteal defect, inadequate luteal phase clomiphene dosage, progesterone level day 21 clomiphene, infertility low progesterone clomid treatment, luteal phase progesterone clomiphene pregnancy, cycle defect clomiphene restoration, ovulation induction luteal support clomiphene

Cite this article

Hammond, M. G., & Talbert, L. M. (1982). Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels. *Obstetrics and gynecology*, *59*(3), 275-279.

Related articles